Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.
Key Details
- 1Heartflow is an imaging AI vendor specializing in noninvasive CT-based cardiac tests.
- 2The company raised $364 million from its IPO, up from the original $100 million target.
- 3Shares were sold at $19 each, with over 19 million shares issued.
- 4Heartflow uses CT data to generate personalized 3D models of coronary arteries.
- 5The company reported $126 million in revenue last year, growing 44% year-over-year.
- 6Estimated market opportunity for Heartflow's products exceeds $5 billion.
Why It Matters
This large capital raise highlights both investor confidence and strong demand for AI-powered cardiac imaging solutions. The funding will help Heartflow expand its reach among radiologists and further develop its imaging AI technology.
Source
Radiology Business
Related News
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.
•Radiology Business
UC Irvine Implements AI to Find Lung Cancer Screening Candidates
UC Irvine's radiology department developed an NLP tool to identify patients eligible for lung cancer screening from EHR notes.